Ashlea Campbell

2PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Nov 13, 2025
Acalabrutinib May Offer a New Therapeutic Approach for Consolidation and Maintenance of Primary CNS Lymphoma with Expression of MYD88 and CD79B Gene Variants: A Case Report and Literature Review of Primary CNS Lymphoma in the BTKi Era.

Eleanor Allison, Ashlea Campbell, Anne-Marie Watson

|Dec 26, 2023
Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies.

Ashlea Campbell, Benjamin Teh, Stephen Mulligan

Pageof 1

Frequent Collaborators

1 joint publications

Benjamin Teh

1 joint publications

Shane Gangatharan

1 joint publications

Jeff Szer

1 joint publications

Judith Trotman

1 joint publications

Michael Dickinson

1 joint publications

Matthew Ku

1 joint publications

Gareth Gregory

1 joint publications

Gregory Hapgood

1 joint publications

Tara Cochrane

1 joint publications

Matthew Greenwood

Frequent Collaborators

1 joint publications

Benjamin Teh

1 joint publications

Shane Gangatharan

1 joint publications

Jeff Szer

1 joint publications

Judith Trotman

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

13.7K
The Use of Fluorescent Target Arrays for Assessment of T Cell Responses <em>In vivo</em>
12:09

The Use of Fluorescent Target Arrays for Assessment of T Cell Responses <em>In vivo</em>

Published on : Jun 19, 2014

14.5K
See more related videos

Top Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

13.7K
The Use of Fluorescent Target Arrays for Assessment of T Cell Responses <em>In vivo</em>
12:09

The Use of Fluorescent Target Arrays for Assessment of T Cell Responses <em>In vivo</em>

Published on : Jun 19, 2014

14.5K
See more related videos